Skip to content

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04540081
Acronym
CLOVER
Enrollment
20000
Registered
2020-09-07
Start date
2020-10-05
Completion date
2022-10-05
Last updated
2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Hepatitis C, Lung Cancer, Obesity, Pneumonia, Bacterial, Shingles, Tobacco Use Cessation

Brief summary

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Interventions

OTHEREpic Healthy Planet Population Health Module

Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations

Sponsors

University of California, Irvine
CollaboratorOTHER
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\- Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

Exclusion criteria

\- Patients outside of the age limits or have an established PCP.

Design outcomes

Primary

MeasureTime frameDescription
Overall Adherence to CLOVER Metrics6 monthsThis is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for

Secondary

MeasureTime frameDescription
Lung cancer screening6 monthsProportion of eligible patients who completed lung cancer screening.
Tobacco cessation counseling6 monthsProportion of eligible patients who completed tobacco cessation counseling.
Obesity counseling6 monthsProportion of eligible patients who completed obesity counseling.
Colon cancer screening6 monthsProportion of eligible patients who completed colon cancer screening.
Shingles vaccination6 monthsProportion of eligible patients who completed shingles vaccination.
Hepatitis C screening6 monthsProportion of eligible patients who completed hepatitis C screening.
Pneumonia vaccination6 monthsProportion of eligible patients who completed pneumonia vaccination.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026